Floatz logo

10 assets in Severe Hemophilia A

Therapeutic assets addressing Severe Hemophilia A, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Human Antihemophilic Factor/Von Willebrand Factor Complex
Severe Hemophilia A
AryoGen Pharmed Co.P4BBB (75)
Emicizumab
Severe Hemophilia A
Chulalongkorn UniversityP4BBB (73)
Frsw117
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.P3BB (68)
Efanesoctocog Alfa
Severe Hemophilia A
Swedish Orphan BiovitrumP3BB (64)
Antihemophilic Factor, Human Recombinant Residues 722-1672 Deleted
Severe Hemophilia A
OctapharmaP4B (62)
Factor Viii, Recombinant Human With Fc Fusion
Severe Hemophilia A
AryoGen Pharmed Co.P3B (62)
Frsw107
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.P3B (60)
gs1191-0445
Severe Hemophilia A
Gritgen Therapeutics Co., Ltd.P1/2CC (47)
Immunoglobulin G1, Anti-(Human Tissue Factor Pathway Inhibitor) (Human Monoclonal Pf-06741086 .Gamma.1-Chain), Disulfide With Human Monoclonal Pf-06741086 .Lambda.-Chain, Dimer
Severe Hemophilia A
PfizerP1CC (43)
Skp-0141
Severe Hemophilia A
SK Plasma Co., Ltd.P3NR ()